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General Introduction
 4 
There are several imaging modalities available in human and small 
animal practice including radiography, ultrasonography (US), computed 
tomography (CT) and magnetic resonance imaging. Among them, CT is 
widely applied in human medicine because it allows obtaining 
comprehensive and objective images in a relatively short time. Recently, 
along with the development of multi-detector row CT, high-speed and 
high-resolution imaging has become possible. Since high-speed imaging 
enabling multi-phasic contrast enhanced CT, it is possible to apply CT to 
precise evaluation of blood vessels and differential diagnosis of certain 
diseases. 
Primary hepatic and pancreatic diseases are relatively common in 
veterinary clinical practice. There are several examinations to detect or 
diagnose hepatic and pancreatic diseases. While blood examination is useful 
for detecting or diagnosing some of the hepatic and pancreatic diseases, 
further imaging diagnosis is essential for definitive diagnosis or treatment 
planning in some of these diseases. For example, congenital portosystemic 
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shunt (cPSS) is one of the diseases of such kind. As cPSS is a disease of 
abnormal vessel originates from the portal system and connects to the 
systemic circulation, causing neurological, urological and systemic disorders. 
Although elevated fasting serum ammonia concentration and/or 
post-prandial serum bile acid concentration are reported to be useful for the 
detection of cPSS in dogs (Gerritzen-Bruning et al., 2006), visualization of 
abnormal shunt vessel is needed for definitive diagnosis. It has been 
reported that ultrasonography (US) is one of the useful imaging modality to 
detect abnormal blood vessels in cPSS dogs (d’Anjou, 2004). Computed 
tomography (CT) is another imaging modality that is more useful for 
definitive diagnosis of cPSS than US in dogs. CT portography allows 
evaluating the morphological features of the shunt vessels in detail and 
classifying the anatomical shunt types (Nelson et al., 2011). Since cPSS can 
be cured by surgical attenuation of the shunt vessels, accurate 
understanding of the shunt vessels prior to surgery is important part of the 
diagnosis and treatment. In Chapter 1, in order to obtain information that is 
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useful for improving diagnostic accuracy of the extrahepatic congenital 
portosystemic shunt (EH-cPSS), I classified the EH-cPSS based on CT 
portographic findngs and clarified the clinical features of each shunt type. 
Imaging diagnosis is also important for the diagnosis of hepatic 
mass forming diseases. It is known that US is quite useful screening 
examination to detect hepatic mass lesions. However, since information 
obtained by CT including size, number, location, vascular distribution of the 
tumor and presence or absence of metastasis, it is useful not only for 
detection but for staging and surgical planning superior to US. Actually in 
human medicine, CT is recommended in the patients with hepatic mass 
lesions for diagnosis and staging of the tumor (Choi et al., 2014). 
Additionally, characteristic multiphasic CT findings of each hepatic mass 
lesion have been well described: e.g. hyper-attenuation in the arterial phase 
and hypo-attenuation in the venous phase were common findings in the 
progressed hepatocellular carcinoma. There are a lot of literatures regarding 
CT findings of hepatic mass lesions in human medicine, and relevant 
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systematic reviews described that the sensitivity of multi-phasic CT to 
diagnose hepatocellular carcinoma was 68 to 91% (Choi et al., 2014; Lee et 
al., 2015). However in the veterinary medicine, information about 
multi-phasic CT in the patients with hepatic mass lesions is quite limited. 
Therefore, in Chapter 2, image features of triple-phase CT to differentiate 
hepatic mass lesions were evaluated. 
The pancreas is the largest gland in the digestive system and has 
both exocrine and endocrine functions. Although some exocrine and 
endocrine pancreatic disorders can be detected by blood examination (e.g. 
pancreatitis, pancreatic insulinoma), imaging is the important part of 
diagnosis and treatment planning. The pancreas is located in the cranial 
abdomen. The right lobe lies inside to dorsal to the descending duodenum 
and the left lobe lies dorsocaudal to the stomach and transverse colon. 
Although US is an useful imaging modality, the utility of US to evaluate the 
pancreas depends on each operator’s skill, capability of the US equipment 
and interference from gastrointestinal contents (Penninck, 2013). In contrast, 
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CT is a useful modality to obtain the entire and objective images of the 
pancreas. Therefore, it is recommended to perform CT examination for the 
patients with pancreatic tumors in human medicine (Furlow, 2015). There is 
a review in which characteristic CT findings of pancreatic tumors were well 
described in humans (de la Santa t et al., 2014). In that review, while the 
primary lesions of pancreatic adenocarcinoma showed hypo-attenuation at 
arterial phase, the metastatic lesions in the liver showed hypo-attenuation 
at portal phase in dual-phase CT. In contrast, it is common that the lesions 
with pancreatic insulinoma present hyper-attenuation in the arterial phase 
(Gouya et al., 2003; Liu et al., 2009). As described above, since CT findings of 
pancreatic tumors are well documented in humans, these findings are 
conceivably helpful to make a diagnosis of pancreatic tumors in dogs. In 
chapter 3, I evaluated image features of triple-phase CT to detect the canine 
pancreatic insulinomas. 
 Although CT is indispensable for the diagnosis and treatment 
planning of the diseases described above, information and evidence of their 
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CT findings are quite limited in small animal medicine. Therefore, each 
study in this thesis is focused on to clarify clinical features and characteristic 
CT findings of these diseases consequently improving the diagnostic 
accuracy, facilitating treatment choice and developing novel diagnostic 
methods of these diseases. 
.
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Chapter 1 
Computed tomographic morphology and 
clinical features of extrahepatic portosystemic 
shunts in 172 dogs in Japan 
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Abstract 
Canine extrahepatic congenital portosystemic shunts (EH-cPSS) are 
classified into several anatomic types, depending on their origin and 
termination of the shunt vessel. The aim of this chapter was to determine 
the proportion and clinical features of each anatomical shunt type in a 
population of dogs presented to the Veterinary Medical Center at the 
University of Tokyo. Dogs diagnosed with EH-cPSS using CT portography 
were included (n = 172) and shunts were classified based on previous reports. 
Clinical data were collected from case records and analyzed statistically. The 
most common anatomical type was the spleno-phrenic shunt (n = 64), 
followed by the spleno-azygos (n = 38), right gastric-caval (n = 29), 
spleno-caval (n = 21), right gastric-caval with caudal loop (n = 9), right 
gastric-phrenic (n = 6), colono-caval (n = 3), spleno-phrenic and azygos (n = 1), 
and porto-caval shunts (n = 1). Spleno-phrenic and spleno-azygos shunts 
were diagnosed significantly more frequently in older dogs than right 
gastric-caval and spleno-caval shunts (P < 0.05). The portal vein/aortic 
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(PV/Ao) ratio was significantly larger in dogs with spleno-phrenic shunt than 
in dogs with the spleno-azygos, right gastric-caval or spleno-caval shunts (P 
< 0.05). The PV/Ao ratio was significantly larger in dogs with spleno-azygos 
shunts than in dogs with right gastric-caval shunts. Dogs with 
spleno-phrenic shunts had significantly lower serum alkaline phosphatase 
activities than those with right gastric-caval or spleno-caval shunts. Dogs 
with spleno-phrenic shunts had significantly lower fasting ammonia 
concentrations than those with spleno-caval shunts. Since several clinical 
features evaluated in this chapter were significantly different depending on 
shunt types, thorough evaluation of shunt morphology by using CT 
portography is essential for the diagnosis of EH-cPSS in dogs. 
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Introduction 
The prevalence of the congenital portosystemic shunt (cPSS) in dogs 
is reported to be 0.06-0.2% (Center, 1996). Extrahepatic congenital 
portosystemic shunts (EH-cPSS) are commonly diagnosed in young, 
purebred, and small breed dogs such as Yorkshire terriers, Maltese, 
Miniature schnauzers, and Cairn terriers. EH-cPSS are classified 
anatomically by their origin and termination. The four major shunt types are 
the spleno-caval, spleno-azygos, right gastric-caval, and right gastric-azygos 
shunts. Although some other types of shunt have also been reported, these 
are quite rare (Szatmari et al., 2006). 
Intraoperative mesenteric portography was formerly the most 
common method for the definitive diagnosis of EH-cPSS (Martin, 1993). Less 
invasive methods, such as ultrasonography (US) and computed tomographic 
(CT) portography, are recently used more commonly (d’Anjou et al., 2004; 
Zwingenberger et al., 2005). In particular, CT portography is useful for 
preoperative diagnosis and surgical planning, reducing the morbidity and 
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time associated with surgery (Frank et al., 2003). More recently, the 
anatomical classification of the EH-cPSS in CT portography has been 
reported in detail and several novel types have been reported, including the 
spleno-phrenic shunt (Nelson et al., 2011). Spleno-phrenic shunts have a 
characteristic termination of the shunt vessel, which drains into the caudal 
vena cava (CVC) cranial to the liver.  
Since the relationship between different anatomical types of 
EH-cPSS and their clinical features has not been fully evaluated, the 
purpose of the study in this chapter was to clarify the proportion and clinical 
characteristics of each anatomical shunt type. 
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Materials and methods 
Medical records from dogs diagnosed with EH-cPSS using CT 
portography at the Veterinary Medical Center at the University of Tokyo 
(VMC-UTokyo) from April 2007 to November 2012 were included in this 
study. Clinical data collected included breed, age, sex, body weight, and 
clinical signs related to the cPSS (seizure, depression, salivation, vomiting, 
and blindness) at first presentation to VMC-UTokyo. The results of blood 
test such as fasting ammonia (NH3), pre- and post-prandial serum bile acid 
(SBA), blood urea nitrogen, serum glucose, serum albumin, alanine 
aminotransferase, and alkaline phosphatase (ALP) were also collected. In 
the dogs that underwent surgery, the difference of portal vein pressure 
before and after temporary occlusion of the shunt vessel, and the presence or 
absence of postoperative complications (post-ligation seizure, ascites, and 
gastrointestinal congestion) within 3 weeks were recorded. 
Image analysis 
All images were carefully reviewed on Osiri X (Pixmeo, Geneva, 
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Switzerland). Anatomical shunt types were classified based on the previous 
report (Nelson et al., 2011) and novel classifications were made as necessary. 
The portal vein diameter was measured on transverse images halfway 
between the entrance of the gastroduodenal vein and the right portal branch 
to the liver. The aortic diameter was measured on the same transverse 
images. The portal vein/aortic (PV/Ao) ratio was calculated using these 
values (Nelson et al., 2011). If the portal vein was undetectable at the 
previously noted location, the PV/Ao ratio was considered to be zero. The 
presence or absence of uroliths was also noted. 
Statistical analysis 
To evaluate the predisposition of EH-cPSS in each breed, all cases 
presented to VMC-UTokyo during the study period were used as the 
reference population. The odds ratio and 95% confidence interval (95% CI) 
were calculated if the number of cases was >5 in each breed category. If the 
lower limit of the 95% CI was >1, this considered to represent a significantly 
higher risk of EH-cPSS in the breed (P < 0.05). 
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To compare the clinical data for each morphologic classification, the 
Kruskall-Wallis test was used for statistical analysis and post-hoc 
comparison were performed using Dunn’s multiple comparison tests. P 
values < 0.05 were considered to be significant. Groups of >10 cases for each 
anatomic shunt type were evaluated statistically. 
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Results 
Medical record from 172 dogs were analyzed, consisting of 79 males 
(29 castrated) and 93 females (34 spayed). The median age and body weight 
were 22 months (range, 2–116 months) and 3.1 kg (range, 1–11.1 kg), 
respectively. Affected breeds and odds ratios are summarized in Table 1-1. 
Yorkshire terrier, Toy Poodle, Papillon, Miniature schnauzer and Norfolk 
terrier were at higher risk of having EH-cPSS (P < 0.05). 
The most common anatomical type was the spleno-phrenic shunt (n 
= 64) followed by spleno-azygos (n = 38), right gastric-caval (n = 29), 
spleno-caval (n = 21), right gastric-caval with caudal loop (n = 9), right 
gastric-phrenic (n = 6), colono-caval (n = 3), spleno-phrenic and azygos (n = 1), 
and porto-caval shunts (n = 1). Individual breed numbers for each of the 
major 4 shunt types (spleno-phrenic, spleno-azygos, right gastric-caval, and 
spleno-caval shunts) are shown in Table 1-2 and their clinical features are 
summarized in Table 1-3. Volume rendering color images of representative 
examples of each of the four most prevalent shunt types are shown in Figure 
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1-1. Statistical analysis revealed a significant difference in age, PV/Ao ratio, 
fasting ammonia concentrations, and ALP activities among the shunt types 
(P < 0.05). 
Spleno-phrenic shunts were diagnosed at a significantly older age 
than right gastric-caval and spleno-caval shunts (P < 0.001). Spleno-azygos 
shunts were diagnosed at a significantly older age than right gastric-caval 
and spleno-caval shunts (P < 0.05, P < 0.01, respectively; Figure 1-2). 
PV/Ao ratios were significantly larger for spleno-phrenic shunt 
(median, 0.83) than spleno-azygos (median, 0.62; P < 0.01), right 
gastric-caval (median, 0.55; P < 0.001), and spleno-caval shunts (median, 
0.55; P < 0.001). Spleno-azygos shunts were associated with significantly 
larger PV/Ao ratios than right gastric-caval shunt (P < 0.05; Figure 1-3). 
Patients with spleno-phrenic shunts had significantly lower serum ALP 
activities than those with right gastric-caval and spleno-caval shunts (P < 
0.01; Figure 1-4). Patients with spleno-phrenic shunt had significantly lower 
fasting ammonia concentrations than those with spleno-caval shunt (P < 
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0.01; Figure 1-5). There were no significant differences in any other 
parameters evaluated in this study. 
Clinical data for dogs with other types of shunts that were each 
represented at least three times in the study populations are shown in Table 
1-3. Since the number of dogs with each of these shunt types was small, 
statistical analysis was not performed in these cases. Volume rendering 
images of these three shunt types are described in Figure 1-6.  
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Discussion 
Spleno-phrenic shunts were the most common type of EH-cPSS in 
this population of dogs in Japan (37.2%). This is different from a previous 
report from North America, in which spleno-azygos shunts were the most 
common (32%), followed by spleno-caval (24%) and spleno-phrenic shunts 
(16%) (Nelson et al., 2011). Since Miniature dachshunds and Toy poodles are 
popular in Japan and had relatively high prevalence of spleno-phrenic 
shunts (Table 7), geographical breed distribution or genetic bias may be 
responsible for this discrepancy. 
Spleno-phrenic shunts were diagnosed at a significantly older age 
than right gastric-caval and spleno-caval shunts. Additionally, 
spleno-phrenic shunt presented with significantly larger PV/Ao ratios than 
the other shunt types. The phrenic vein drains into the CVC caudal to the 
diaphragm and cranial to the liver, and easily collapses with each 
respiratory cycle. This could contribute to decreased shunt fraction and 
result in latent clinical signs and preserved size of portal vein. Unfortunately, 
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because no cases underwent scintigraphy, the exact shunt fraction of each 
case was unknown. It has been reported that dogs with PV/Ao ratios >0.8 did 
not have the EH-cPSS on US evaluation (D’anjou et al., 2004). However, 38 
out of 64 cases in this study with spleno-phrenic shunts had PV/Ao ratios 
>0.8. Although different imaging modalities (US and CT) were used in the 
two studies, this type of shunt might not be diagnosed by US screening based 
on determining the PV/Ao ratio. The World Small Animal Veterinary 
Association (WSAVA) has established standardized methodology for US 
diagnosis of portosystemic shunts (Szatmari et al., 2006). This standardized 
method is based on the concept that the shunts with caval termination drain 
into the CVC at the same location, i.e., slightly cranial to where the celiac 
artery originates from the aorta. Since the spleno-phrenic shunt drains into 
the CVC cranial to the liver, the termination of this shunt type cannot be 
detected by using the WSAVA method. 
In addition, while the shunt vessel of the spleno-phrenic shunt is 
situated at the left and dorsal part of the body, the WSAVA method for PSS 
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mainly consists of planes from the right side of the body. Therefore, 
spleno-phrenic is potentially difficult to detect and it might not be visualized 
using these standardized planes. Since the spleno-phrenic shunt was 
relatively common in Japan, other diagnostic workup should be considered 
by analyzing the results obtained in this study. 
Spleno-azygos shunts were diagnosed in significantly older dogs 
than right gastric-caval and spleno-caval shunts. This result corresponded to 
a previous report (Van den Bossche et al., 2012), but the present study was 
able to describe the shunt morphology in more detail. Furthermore, 
spleno-azygos shunts had a significantly larger PV/Ao ratios than right 
gastric-caval shunts. In normal dogs, the diameter of the azygos vein is 
smaller than that of the CVC. Therefore, resistance to blood flow might be 
higher in azygos shunts than in caval shunts when the shunt vessels drain 
into the systemic circulation. This could result in relatively sustained PV 
diameter in spleno-azygos shunt compared to those in caval shunt, which 
have lower blood flow resistance. Additionally, most spleno-azygos shunts 
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have distinctly tortuous morphology, which could contribute to reduced blood 
flow. Furthermore, since azygos shunts penetrate the dorsal diaphragm and 
drain into the thorax, increased intrathoracic pressure or respiratory 
movement may also result in reduced blood flow. These mechanisms are 
likely similar to that of the spleno-phrenic shunts. 
Serum ALP activities in dogs with spleno-phrenic shunts were 
significantly lower than those with right gastric-caval and spleno-caval 
shunts. Serum ALP activity (mainly bone-derived ALP) is highest during the 
first 16 weeks of life and then continued to decrease until 1 year of age 
(Fernandez et al, 2007). Since the age at diagnosis was significantly older in 
the spleno-phrenic shunt (median, 51.5 months) than in the right 
gastric-caval (median, 10.5 months) and spleno-phrenic shunts (median, 6 
months), age might be responsible for these differences in serum ALP 
activities. 
Fasting serum NH3 concentrations were significantly lower in dogs 
with spleno-phrenic shunts (median, 87.5 µg/dL) than in those with 
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spleno-caval shunts (median, 171 µg/dL). In a previous report, there were no 
cPSS case among 132 dogs with fasting serum NH3 < 78 µg/dL 
(Gerritzen-Bruning, 2006). In the study of this chapter, 26 out of 64 
spleno-phrenic shunt cases presented with serum fasting NH3 
concentrations < 78 µg/dL. Reduced blood flow associated with the 
anatomical morphology of the shunt vessel may explain this difference. 
Regardless of shunt type, post-prandial SBA concentrations were elevated in 
most of the cases with EH-cPSS (99.3%) in the present study. Post-prandial 
SBA was the most sensitive biochemical screening test for the EH-cPSS. 
This study revealed that Yorkshire terriers, Toy poodles, Papillons, 
Miniature schnauzers, and Norfolk terriers were at a significantly higher 
risk for the EH-cPSS in this Japanese population. These results are similar 
to previous reports from the Netherlands and North America (Van den 
Bossche et al., 2012; Nelson et al., 2011), with the exception of the high 
prevalence of EH-cPSS in Toy poodles in Japan. Toy poodles have became 
popular in Japan over the last decade and inbreeding might have resulted in 
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an increased risk of inherited conditions. A recent report showed no 
difference in breed distributions for porto-caval and porto-azygos shunts 
(Van den Bossche et al., 2012), although anatomical shunt types were not 
classified in detail. Further investigation is needed to clarify potential breed 
predispositions to EH-cPSS and veterinarians must make effort to avoid 
inappropriate breeding. 
In conclusion, spleno-phrenic shunts were the most common type of 
canine EH-cPSS in this study and there were significant clinical differences 
among anatomical shunt types, including age at presentation, PV/Ao ratio, 
serum ALP activity, and fasting serum NH3 concentration. It is important to 
determine EH-cPSS morphology in detail and to understand that certain 
types of EH-cPSS could be difficult to detect using current diagnostic 
methods. 
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Table 1-1 
Number of dogs of different breeds and odds ratios for extrahepatic congenital portosystemic 
shunts 
Breed n Odds ratio (95% CI) a 
Yorkshire terrier 28 4.10* (2.75–6.12) 
Miniature dachshund 25 0.91 (0.60–1.39) 
Toy poodle 18  1.85* (1.14–3.00) 
Shih Tzu 16 1.66 (0.99–2.77) 
Papillon 14 3.34* (1.94–5.73) 
Miniature schnauzer 11 2.55* (1.39–4.68) 
Chihuahua 11 0.90 (0.49–1.65) 
Maltese 9 1.73 (0.89–3.38) 
Norfolk terrier 8 24.00* (12.4–46.2) 
Pug 5 1.89 (0.78–4.57) 
Pomeranian 4 ND b 
West Highland white terrier 3 ND b 
Others d 20 ND b 
a 95% CI, 95% confidence interval 
b ND, not determined 
c Breeds with a significantly higher risk of extrahepatic congenital portosystemic shunt 
d Pembroke Welsh Corgi, Shetland sheepdog, Italian greyhound (n = 2 for each breed) 
 Shiba, Miniature pinscher, Bolognese, Jack Russell terrier, Cairn terrier (n = 1 for each 
breed) 
 Crossbred (n = 9) 
* Breeds with significantly higher risk of EX-cPSS 
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Table 1-2 
Number of dogs of different breeds with each shunt type 
 Spleno-phrenic Spleno-azygos RG a-caval Spleno-caval 
Yorkshire terrier 5 6 7 5 
Miniature dachshund 12 3 3 2 
Toy poodle 8 8 0 1 
Shih Tzu 6 4 2 1 
Papillon 6 3 1 0 
Miniature schnauzer 8 1 0 1 
Chihuahua 7 0 3 0 
Maltese 0 1 5 2 
Norfolk terrier 1 4 2 1 
Pug 2 1 1 0 
Others 9 7 5 8 
Total 64 38 29 21 
a RG, right gastric 
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Table 1-3. Clinical features of the four major shunt types 
 
Spleno-phrenic 
(n = 64) 
Spleno-azygos 
(n = 38) 
RGa-caval 
(n = 29) 
Spleno-caval 
(n = 21) 
Age (months) 
51.5 1 
(4–128) 
33.5 2, 3 
(3–86) 
10.5 1, 3 
(3–95) 
6 1, 2 
(2–81) 
Clinical signs (n) 27/61 17/37 14/26 10/20 
Fasting NH3 (mcg/dL) 
87.5 2 
(24–748) 
104 
(46–393) 
135 
(53–490) 
171 2 
(53–354) 
Pre-prandial SBAb (nmol/L) 
105.1 
(5.8–400.0) 
89.4 
(19–543.3) 
137.2 
(15.1–539.7) 
87.7 
(13.9–437.8) 
Post-prandial SBAb (nmol/L) 
224.5 
(21.7–502.5) 
226.3 
(49.0–432.8) 
239.5 
(78.3–613.7) 
250.0 
(126.9–490.0) 
BUNc (mg/dL) 
6.5 
(2.1–23.9) 
5.9 
(2.4–13.3) 
6.3 
(1.6–12.6) 
6.4 
(1.1–12.6) 
Glucose (mg/dL) 
89.5 
(44–131) 
92 
(28–137) 
91.5 
(59–125) 
83 
(48–127) 
Albumin (g/dL) 
2.9 
(1.2–3.4) 
2.8 
(1.8–3.8) 
2.6 
(1.5–3.4) 
2.7 
(1.2–3.2) 
ALTd (U/L) 
84 
(22–595) 
95.5 
(28–1,985) 
108 
(51–805) 
103.5 
(30–1,391) 
ALPe (U/L) 
197 2 
(61–2,600) 
263.5 
(116–1,674) 
462.5 2 
(142–1,924) 
546.5 2 
(99–2,165) 
PV/Aof ratio 
0.831, 2 
(0.37–1.31) 
0.62 2, 3 
(0–1.30) 
0.551, 3 
(0–0.75) 
0.551 
(0–1.03) 
Presence of urolith (n) 23/64 23/38 16/29 13/21 
Received surgery (n) 30/53 (56.6%) 27/34 (79.4%) 21/25 (84.0%) 16/19 (84.2%) 
PVPg difference (mmHg) 
5 
(0–33) 
6 
(1–42) 
9 
(0–19) 
5.5 
(1–37) 
Post-surgical complications (n) 1/30 1/27 3/21 2/16 
1 P < 0.001, 2 P < 0.01, 3 P < 0.05 
a RG, right gastric, b SBA, serum bile acid, c BUN, blood urea nitrogen, d ALT, alanine 
aminotransferase, e ALP, alkaline phosphatase, f PV/Ao, portal vein/aorta, g PVP, portal 
venous pressure, Median (range) shown when applicable.  
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Table1-4 Clinical features of the minor shunt types 
 
RGa-caval Ca loop 
(n = 9) 
RGa-phrenic 
(n = 6) 
Colono-caval 
(n = 3) 
Age (months) 
44.0 
(7–98) 
16.0 
(12–68) 
65.0 
(13–92) 
Clinical signs (n) 5/9 1/5 2/3 
Fasting NH3 (mcg/dL) 
217 
(62–515) 
114 
(86–256) 
62 
(53–72) 
Pre-prandial SBAb (nmol/L) 
157.0 
(58.9–348.6) 
122.8 
(24.6–271.9) 
213.7 
(59.4–372) 
Post-prandial SBAb (nmol/L) 
237.2 
(34.8–329.7) 
248.3 
(177.8–281.4) 
251.8 
(250.0–253.5) 
BUNc (mg/dL) 
7.9 
(3.6–13.5) 
8.4 
(3.7–15.3) 
6.1 
(5.3–12.8) 
Glucose (mg/dL) 
82.0 
(61–97) 
75 
(57–88) 
105 
(93–116) 
Albumin (g/dL) 
2.7 
(2.3–3.1) 
2.5 
(2.0–2.7) 
3.3 
(3.2–3.4) 
ALTd (U/L) 
121 
(47–327) 
107 
(44–605) 
64 
(49–305) 
ALPe (U/L) 
247 
(158–973) 
227 
(185–473) 
240 
(125–542) 
PV/Aof ratio 
0.57 
(0.43–0.74) 
0.52 
(0.39–0.99) 
0.91 
(0.51–1.04) 
Presence of urolith (n) 5/9 2/6 1/3 
Received surgery (n) 6/9 (66.6%) 4/6 (66.6%) 2/3 (66.6%) 
PVPg difference (mmHg) 
5 
(1–8) 
7 
(2–8) 
6 
(–) 
Post-surgical complications (n) 0/6 1/4 0/1 
a RG, right gastric, b SBA, serum bile acid, c BUN, blood urea nitrogen, d ALT, alanine 
aminotransferase, e ALP, alkaline phosphatase, f PV/Ao, portal vein/aorta, g PVP, portal 
venous pressure, Median (range) shown when applicable.  
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Figure 1-1 
 
Legend for figure 1-1. 
Volume rendering images of dogs with major 4 types of shunt types (red vessel, aorta; blue vessel, 
caudal vena cava; yellow vessel, portal vein; green vessel, shunt vessel; Cr, cranial; Ca, caudal; L, Left; 
R, Right). (A) Spleno-phrenic shunt as viewed from the left cranial aspect. The shunt vessel originates 
from the splenic vein (arrow head) and runs cranially, then drains into the caudal vena cava cranial to 
the liver (arrow). Note that the shunt vessel is flattened between the diaphragm and the liver. The 
intrahepatic portal vein was relatively sustained in this type of shunt. (B) Spleno-azygos shunt as 
viewed from the left cranial aspect. The shunt vessel originates from the splenic vein (arrow head) and 
runs dorsally with tortuous morphology, then drain into azygos vein (arrow). (C) Right gastric-caval 
shunt as viewed from the ventral aspect. The shunt vessel originates from the right gastric vein (arrow 
head) and runs laterally to the left, then drain into CVC (arrow). (D) Spleno-caval shunt as viewed 
from the left cranial aspect. Shunt vessel originate from the splenic vein (arrow head) then drain into 
CVC (arrow).  
A B
C D
   
  
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Figure 1-2 
 
Shunt type and age at first presentation. Age at first presentation was analyzed in the four 
major types of the extrahepatic congenital portosystemic shunt. Spleno-phrenic and 
spleno-azygos shunts were diagnosed at a significantly older age than the other two shunt 
types. The horizontal line indicates the median. 
a RG, right gastric 
*** P < 0.001, ** P < 0.01, * P < 0.05  
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Figure 1-3 
 
Shunt type and portal vein/aorta ratio. The portal vein/aorta (PV/Ao) ratio was analyzed in 
the four major types of the extrahepatic congenital portosystemic shunt. The spleno-phrenic 
shunt has a significantly larger PV/Ao ratio than the other shunt types, and the 
spleno-azygos shunt had a significantly larger PV/Ao ratio than the right gastric-caval 
shunt. 
The horizontal line indicates the median. 
a RG, right gastric 
*** P < 0.001, ** P < 0.01, * P < 0.05  
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Figure 1-4 
 
Shunt type and serum ALP activity. ALP activity was analyzed in the four major types of 
the extrahepatic congenital portosystemic shunt. The spleno-phrenic shunt has a 
significantly lower ALP level than the right gastric-caval and spleno-caval shunt. 
The horizontal line indicates the median. 
a RG, right gastric 
** P < 0.01  
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Figure 1-5 
 
Shunt type and fasting NH3 concentration. Fasting NH3 concentration was analyzed in the 
four major types of the extrahepatic congenital portosystemic shunt. The spleno-phrenic 
shunt has a significantly lower fasting NH3 concentration than the spleno-caval shunt. 
The horizontal line indicates the median. 
a RG, right gastric 
** P < 0.01  
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Figure 1-6 
 
Legend for Figure 1-6. 
Volume rendering images of dogs with 3 types other than major 4 types (Cr, cranial; Ca, caudal; L, 
Left; R, Right). (A) Right gastric-caval shunt with caudal loop as viewed from the left ventral aspect. 
The shunt vessel originates from the right gastric vein and runs laterally to the left (white arrow 
heads), join together with caudal loop originate from splenic vein (yellow arrow heads), then drains 
into CVC (arrows). (B) Right gastric-phrenic shunt as viewed from the ventral aspect. The shunt vessel 
originates from the right gastric vein (arrow heads) and runs laterally to the left side. (C) Right 
gastric-phrenic shunt as viewed from the left cranial aspect. The shunt vessel drain into CVC (arrows) 
cranial to the liver. (D) Colono-caval shunt as viewed from the ventral aspect. The colonic vein drains 
into CVC at caudal end of the CVC (arrow heads). 
 
 
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Chapter 2 
Computed tomographic characteristics 
of hepatic mass lesions in dogs 
 38 
Abstract 
 Little information is available on the relationship between computed 
tomography (CT) imaging findings and the pathologic diagnosis of canine hepatic 
tumors. The purpose of the study in this chapter was to clarify the characteristic features 
of CT findings in hepatic tumors in dogs. Data from 43 dogs with either a hepatocellular 
carcinoma (n = 14), hepatocellular adenoma (n = 14), nodular hyperplasia (n = 5) or 
other malignancies (n=10) were summarized from medical records. CT features for each 
hepatocellular tumor were characterized and analyzed statistically. Common findings in 
hepatocellular carcinoma included central (79%, P = 0.036) and marginal enhancement 
(93%, P = 0.00043) in the arterial phase, cyst-like lesions (93%), capsule formation 
(93%), and hypoattenuation in the portal (86%, P = 0.043), and in the equilibrium 
phases (93%, P = 0.013). Hepatic adenoma was characterized by a characteristic diffuse 
enhancement pattern during the arterial phase (57%, P = 0.0013), which was also found 
in nodular hyperplasia (60%), but never in hepatocellular carcinoma. Nodular 
hyperplasia was less likely to have a capsule structure (20%, P = 0.0087). Mass size 
was significantly smaller in nodular hyperplasia than in hepatocellular carcinoma and 
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hepatic adenoma (P = 0.0033 and 0.038, respectively). Hyperattenuation in the arterial 
and the portal phase i.e. contrast retention, was more frequent in hepatic adenoma than 
in the other groups (P = 0.032 and 0.032, respectively). Nodular hyperplasia was more 
frequently isoattenuating in the equilibrium phase (P = 0.043). In other malignancies 
group, all hemangiosarcoma (n=4) cases showed cyst-like lesions and hypo-attenuation 
in all phases. The patients with hepatic carcinoid tumor (n=2) showed contrast 
enhancement in the margin of the tumors in the arterial and portal phases. Findings 
obtained in this study will help to differentiate hepatic mass lesions in dogs using 
triple-phase CT examination. 
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Introduction 
The prevalence of primary hepatic tumors in dogs is 0.6–0.9% 
(Patnaik et al., 1980; Strombeck et al., 1978). Hepatic tumors were classified 
into hepatocellular neoplasia, cholangiocellular neoplasia, hepatic carcinoid 
and hepatoblastoma, primary vascular and mesenchymal neoplasia, 
hematopoietic neoplasia and metastatic neoplasia (Cullen et al., 2009). Of 
these hepatic tumors, hepatocellular carcinoma (HCC) was the most common, 
followed by bile duct carcinoma, carcinoid tumor, and sarcoma. Liver tumors 
in dogs are classified macroscopically into massive, diffuse, and nodular 
tumors (Patnaik et al., 1981), and are classified histologically into various 
types of benign and malignant tumors. Solitary or massive HCC has a good 
prognosis when resected completely (Liptak et al., 2004; Kosovsky et al., 
1989), whereas dogs with other types of malignancy have a poor prognosis. 
Moreover, nodular hyperplasia (NH) involves benign hyperplastic nodules of 
hepatocellular tissues and sometimes mimics hepatic neoplasia in dogs 
(Cuccovillo et al., 2002). In one study, 70% of necropsied dogs had 
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macroscopically visible NH in the liver (Bergman, 1985). Because the 
prognoses of benign lesions and malignant tumors are different, it is 
desirable to predict a precise histological of a mass-forming lesion in the liver. 
Liver biopsy can be used to obtain the definitive diagnosis, but it is invasive 
and distinguishing malignant tumor from benign liver lesions using imaging 
would be valuable. However, information on the relationship between 
histological diagnosis and CT findings is limited in small animal practice 
(Taniura et al., 2009). Therefore, the purpose of the study in this chapter was 
to characterize the triple-phase CT findings in different types of hepatic 
mass lesions in dogs. 
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Materials and Methods 
Case selection 
Dogs that underwent abdominal helical triple-phase CT for 
evaluation of hepatic mass lesions (i.e. hepatocellular carcinoma (HCC), 
hepatocellular adenoma (HA), nodular hyperplasia (NH) and other hepatic 
tumors at the VMC-UTokyo between April 2005 and March 2010 were 
included in this retrospective study. The breed, age, sex, and body weight 
were obtained from the medical records. Definitive diagnosis was made 
histopathologically based on previously published criteria, such as the World 
Small Animal Veterinary Association Standards for Histological and Clinical 
Diagnosis of Canine and Feline Liver Diseases (Gaschen et al., 2009). All of 
the cases were histopathologically diagnosed by an experienced pathologist. 
Dogs that were lacking either the data of CT images or the histopathologic 
specimen for reevaluation were excluded from this study. 
All patients had undergone abdominal helical CT evaluation that 
included non-enhanced and contrast enhanced triple-phase CT through the 
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liver. Triple-phase CT scanning was performed as described previously with 
slight modification (Iseri et al., 2007; Winter et al., 2005). CT images were 
acquired with a 4-row multidetector helical CT unit (Asteion Super 4, 
Toshiba Medical Systems Corporation, Tochigi, Japan). The helical 
sequences were acquired using 120kVp and 100-150mA in a standard 
algorithm, with the patient was in dorsal recumbency and under general 
anesthesia. Slice thickness and interval was 1-3 mm with a helical pitch of 
5.5. On triple-phase CT, the scan was initiated at the cranial aspect of the 
diaphragm and extended caudally to the level of the pelvic inlet for plain 
scanning, portal and equilibrium phases. In arterial phase, the scanning was 
extended caudally to the level of end of the liver or the mass lesion. Iohexol 
(300 mg I/ml, Omnipaque 300, Daiichi Sankyo Company. Ltd., Tokyo, Japan) 
was used as the contrast medium at a dose of 2 ml/kg and was injected with 
power injector (A-300, Nemoto Kyorindo Co. Ltd., Tokyo, Japan) over 5 to 10 
seconds via jugular vein. Images were obtained before contrast medium 
injection, in an arterial phase (13 seconds), in a portal phase (30 seconds) 
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and at equilibrium phase (120 seconds) after the contrast medium injection. 
 
Imaging analysis 
Images were analyzed on OsiriX (Pixmeo, Geneva, Switzerland). 
Because HCC was the most frequent diagnosis in this study, I evaluated the 
CT findings on the basis of the past reports of CT images in human 
non-cirrhotic HCC (Brancatelli et al., 2002). 
 The characteristic evaluated included number, distribution, 
bidirectional maximum lesion diameter, and descriptions of margins 
(well-defined or ill-defined) and surfaces (smooth or lobulated). A tumor 
capsule was defined as a thin or thick curvilinear border that surrounded at 
least half of the tumor and had a distinct difference in attenuation. The 
presence or absence of calcification was recorded. Non-enhancing areas with 
attenuation similar to that of the gallbladder contents were regarded as 
cyst-like and representative of necrosis. The presence of tumor fat was 
evident when the tumor components had attenuation lower than that of 
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water on non-enhanced CT images. Tumor thrombus was defined as 
distention of the hepatic and/or portal vein lumen by enhancement of the 
thrombus. Other findings, including dilated bile duct, and hemorrhage were 
assessed in accordance with a previous study (Brancatelli et al., 2002). 
Cranial abdominal lymphadenopathy was noted when ovoid or round 
extravisceral masses were identified adjacent to the portal vein and had a 
ratio of >0.7 (short axis/long axis) (Nyman et al., 2007) or when the masses 
had a long axis of >10 mm and a heterogeneous or ring enhancement pattern 
was observed (Ballegeer et al., 2010). Lymph nodes were evaluated with 
two-dimensional transverse images of the CT. 
Overall attenuation of the tumor was noted, which was defined 
relative to the liver parenchyma during the same phase of imaging; plain, 
arterial, portal, or equilibrium phase. In the assessment of overall 
attenuation, I ensured objectivity by measuring the CT value at the 
cross-section at which the lesion had bidirectional maximum diameter. If the 
lesion had a different CT value in Hounsfield units (HU) (>20 HU compared 
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with the surrounding liver parenchyma), I deemed it to be different and 
considered these lesions to have hyper or hypoattenuation. 
Enhancement patterns of the arterial phase were evaluated in 
terms of 3 categories: central, marginal, and diffuse enhancement (Figure 
2-1). Central enhancement was defined as blood vessels with or without 
dilation located in the central area of the lesion, marginal enhancement as 
blood vessels located along the margin, and diffuse enhancement as blood 
vessels extending entirely within the mass lesion. 
 
Statistical analysis 
 The ratio of positivity or negativity of each finding in each lesion 
type was analyzed by Haberman’s residual analysis. The diameter of the 
mass was compared among all categories by using the Steel-Dwass multiple 
comparison method. A P value of <0.05 was considered significant.  
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Results 
Forty-three dogs met the inclusion criteria. There were 18 males (7 
castrated) and 25 females (17 spayed). The median age and body weight were 
10.5 years (range, 3 months–15 years) and 9.8 kg (range, 1.5–38.5 kg), 
respectively. The Affected breeds were as follows: Shih-Tzu (n=6), Golden 
retriever, Labrador retriever, Mix breed dog (n=4, each), Siberian husky, 
Beagle, Chihuahua (n=3, each), Maltase, Pomeranian, Shetland sheepdog, 
Pembroke Welsh Corgi, Miniature schnauzer, shiba-inu (n=2, each), Tibetan 
spaniel, West Highland white terrier, Italian greyhound, and Yorksher 
terrier (n=1, each). Histopathological diagnoses of hepatocellular tumors 
were HCC (n = 14), HA (n = 14), NH (n = 5). Other malignancies (OM) 
including hemangiosarcoma (HSA; n=4), hepatic carcinoid tumor (CND; n=2), 
lymphoma, lymphangiosarcoma (LSA), malignant mesenchymal tumor 
(MMT) and malignant peripheral nerve sheath tumor (MPNST) (1 case each). 
Because each case number of the OM group was too small, only 
hepatocellular tumors were analyzed statistically. 
 48 
The CT findings of hepatocellular tumors are summarized in Tables 
2-1, 2-2 and 2-3. The characteristics of HCC were large (median diameter, 
105.5 mm; range, 85–165 mm) and had cyst-like or necrotic lesions (n = 13, 
93%) and capsule formation (n = 13, 93%) (Table 2-1). The surface was 
lobulated (n = 8, 57%) or smooth (n = 6, 43%), and the margins were well 
defined (n = 12, 86%). Calcification (n = 3, 21%), hemorrhage (n = 2, 14%), 
dilated bile duct (n = 2, 14%) were observed occasionally. Cranial abdominal 
lymphadenopathy was noted in 5 patients (36%), and no patient had an 
identifiable tumor thrombus. The overall attenuation of HCC was iso (n = 7) 
or hypoattenuating (n = 7) in the arterial phase, but in the portal phase, 
most became hypoattenuating (n=12, 86%). In the equilibrium phase, 
hypoattenuation is significantly more frequent in HCC than in the other 
groups (n = 13, 93%, P = 0.013) (Table 2-2). On enhancement patterns in the 
arterial phase, central (n = 11, 79%, P = 0.036) and marginal (n = 13, 93%, P 
= 0.00043) enhancement were observed significantly more frequently in HCC 
(Table 2-3 and Figure 2-2). 
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The findings of HA (n = 14) were small to large (median diameter, 
85.5 mm; range, 28–114 mm), most of which had well-defined margins (n = 
11, 79%). Most of them showed lobulated surface (n = 12, 86%), cyst-like 
structures (n = 10, 71%), and capsule formation (n = 9, 64%), but they seldom 
had hemorrhage (n = 0, 0%), tumor fat (n = 1, 7.1%), dilated bile ducts (n = 1, 
7.1%), or tumor thrombus (n = 0, 0%). Calcification (n = 2, 14%) and 
lymphadenopathy (n = 5, 26%) were noted in some patients. On overall 
attenuation, hyper-attenuation in both the arterial and the portal phase 
were significantly more frequent in HA (n = 4, 29%, P = 0.032). Out of 14 
patients, eight (57%) had a diffuse enhancement pattern in the arterial 
phase, significantly more frequent than other lesion types (P = 0.0013) 
(Table 2-3 and Figure 2-3). As compared to the other groups, a marginal 
enhancement pattern was a significantly infrequent finding (29%, P = 0.0038, 
Table 2-3). 
NH was significantly smaller than HCC or HA (P = 0.0033 and 
0.038, respectively). The median diameter was 42 mm and ranged from 28 to 
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63 mm. Three patients had a single mass, whereas 2 had multiple masses. 
The surface of the mass was lobulated (n = 3, 60%) or smooth (n = 2, 40%), 
and most patients (n = 4, 80%) had well-defined margins. Cyst-like areas 
were observed in 1 patient (20%) and capsule formation was noted in 1 
patient (20%), these were significantly infrequent (P = 0040 and 0.0087, 
respectively) (Table 2-1). Other findings, such as hemorrhage, tumor fat, 
dilated bile duct, tumor thrombus and calcification were not noted. Lymph 
node enlargement was noted in one patient (20%). On overall attenuation, 
isoattenuation in both the portal and equilibrium phase were observed 
significantly more frequently than other groups (P = 0.046 and 0.021, 
respectively) (Table 2-2 and Figure 2-4). In addition, hypoattenuation in the 
equilibrium phase is significantly less frequent than in other groups (P = 
0.037). A diffuse enhancement pattern in the arterial phase was seen in 3 
patients (60%). 
The CT findings of OM group were summarized in Tables 2-4, 2-5. 
Characteristic findings of HSA including cyst like lesions (4/4) and 
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hypo-attenuation in all phases in triple-phase CT (Figure 2-5). CT features of 
CND (n=2) included multiple-mass lesions (2/2), lobulated mass (2/2), 
capsule formation (2/2) and lymph node enlargement (2/2). In triple-phase 
CT of CND cases, tumor margins were enhanced in the arterial and portal 
phases (Figure 2-6, 2-7). One case showed cystic lesions inside the tumor 
indicating necrotic lesions (Figure 2-7). Remaining cases in OM group (n=4) 
were lobulated (4/4), cystic (4/4), capsulated (4/4) and had multiple lesions 
(3/4). They showed hypo-attenuation in all phases in triple-phase CT. 
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Discussion 
 In a previous report of the CT findings of canine hepatic mass 
lesions (Taniura et al., 2009), only 2 types, hepatocellular carcinoma and 
nodular hyperplasia, were investigated, and most findings were not 
evaluated statistically. In the study of this chapter, I evaluated the 
triple-phase CT findings of hepatocellular tumors classified into 3 groups 
(hepatocellular carcinoma, hepatic adenoma, and nodular hyperplasia) and 
analyze these findings statistically. 
In the study of this chapter, I found that central and marginal 
enhancement patterns in the arterial phase were significantly more frequent 
in canine hepatocellular carcinoma than in the other lesions. This is 
consistent with the previous report in which blood vessels inside the tumor 
were more frequent in hepatocellular carcinoma than nodular hyperplasia 
(Taniura et al., 2009). Other features of canine hepatocellular carcinoma 
included large size, cyst-like lesions, and hypo-attenuation in the portal and 
equilibrium phases. As hepatocellular carcinoma in dogs tends to be 
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diagnosed when the mass becomes large enough to cause a clinical 
abnormality, features such as large size and cyst-like necrotic lesions were 
seen commonly. It has been stated that dogs with hepatocellular carcinoma 
have low attenuation in the portal venous and equilibrium phases (Taniura 
et al., 2009). These findings are comparable to the findings in this chapter of 
early wash out, i.e., hypo-attenuation in the portal and the equilibrium 
phases. Combinations of these findings might be useful for differential 
diagnosis of canine hepatocellular carcinoma using triple-phase CT. 
 A diffuse enhancement pattern in the arterial phase was observed 
significantly more frequent in hepatic adenoma than in other groups. This 
was also observed in nodular hyperplasia, whereas it was not observed in 
hepatocellular carcinoma. Therefore, a diffuse enhancement pattern in the 
arterial phase suggests a benign lesion. This enhancement pattern 
resembles that of hepatic adenoma and focal nodular hyperplasia in humans, 
which is hypervascular in the arterial phase (Hussain et al., 2004; Jang et al., 
2009). This might reflect the difference in vascular distribution between 
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benign and malignant tumors. Microscopic vascular structural changes that 
can cause hypervascularity have been reported in human hepatic adenoma 
and nodular hyperplasia (Grazzioli et al., 2001; Hussain et al., 2004), and 
similar changes might occur in dogs. Because arterial hypervascularity was 
also reported in human patients with hepatocellular carcinoma and cirrhosis 
(Baron et al., 2004), further investigation of this finding in dogs is needed. 
 In the nodular hyperplasia group, masses were significantly smaller, 
and cyst-like lesions and capsule formation occurred less frequently. These 
findings might be due to nodular hyperplasia consisting of age-associated 
hyperplastic nodules (Patnaik et al., 1981; Strombeck et al., 1996), while 
other tumors are proliferative lesions that result in small masses and less 
frequent formation of cyst-like necrotic lesions. The margin of nodular 
hyperplasia being demarcated by compression of the surrounding 
parenchyma without a fibrous capsule (Patnaik et al., 1981), explains the 
decreased frequency of capsule formation in CT findings. Moreover, nodular 
hyperplasia is more frequently iso-attenuating in the equilibrium phase. 
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This is similar to focal nodular hyperplasia, which is iso-attenuating in the 
portal and delayed phases in humans (Brancatelli et al., 2002; Jang et al., 
2009). Although nodular hyperplasia forms small and multiple mass lesions 
in general (Cullen, 2009), relatively large lesions that were considered for 
surgery were included in this study. There is a possibility that this difference 
may affect the results of image findings of NH in this study. 
 Additionally, I described the triple-phase CT findings of other 
hepatic malignancies. Cases with hemangiosarcoma presented characteristic 
findings of cystic lesions and hypo-attenuation in all phases in triple phase 
CT. Hypo-attenuation in the arterial and portal phase in dogs with 
hemangiosarcoma has been reported previously (Kutara et al., 2013). In the 
present study, a case with lymphangiosarcoma showed similar features to 
that of hemangiosarcoma. Since hemangiosarcoma and lymphangiosarcoma 
are tumors of accumulating large amount of fluid (blood or lymph) inside the 
lesion, contrast enhancement should be weak compared to surrounding liver 
parenchyma. These CT findings may be useful to suspect hemangiosarcoma 
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or lymphangiosarcoma in the dogs with hepatic mass lesion. In two cases 
with hepatic carcinoid tumor, contrast enhancement in the margin of the 
tumor at arterial and portal phase was observed. Marginal enhancement of 
hepatic carcinoid tumor has been reported in a contrast ultrasonographic 
study (Nakamura et al., 2010). Although case number is too small, this 
finding might be characteristic for hepatic carcinoid tumor in dogs. Case 
accumulation of triple-phase CT findings of these tumors is essential to 
figure out useful features in differentiating these hepatic tumors. 
 In summary, hepatocellular carcinoma tended to show central or 
marginal enhancement whereas hepatic adenoma was more likely to have 
diffuse enhancement pattern in the arterial phase. Hypo-attenuation in the 
later enhancement time phase was also characteristic for hepatocellular 
carcinoma, whereas contrast retention in portal and equilibrium phase was 
characteristic for benign hepatic lesions such as hepatic adenoma and 
nodular hyperplasia. Hemangiosarcoma tended to show cystic lesion and 
hypo-attenuation in all phases in triple-phase CT. Hepatic carcinoid tumor 
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presented contrast enhancement in the margin of the tumor in the arterial 
and portal phases. These findings will help to diagnose mass lesion in the 
canine liver on triple-phase CT examination. 
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Table 2-1 
Summary of the characteristic CT findings in the dogs with hepatocellular tumors 
  Cyst-like Capsule 
HCC 13 13 
n = 14 
HA 
(93%) 
10 
(93%) 
9 
n = 14 (71%) (64%) 
NH 1* 1* 
n = 5 (20%) (20%) 
 
Each number represents the number and percentage of positive findings. 
*Significantly smaller or larger compared with other cells. 
HCC, hepatocellular carcinoma; HA, hepatocellular adenoma; NH, nodular hyperplasia 
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Table 2-3 
Enhancement Pattern in the Arterial phase of hepatocellular tumors in triple-phase CT 
 
    
  Enhancement pattern (%) 
 Central Marginal Diffuse 
HCC (n = 14) 11* (79%) 13* (93%) 0* (0%) 
HA (n = 14) 4 (29%) 4* (29%) 8* (57%) 
NH (n = 5) 1 (20%) 2 (40%) 3 (60%) 
Numbers represent patient numbers and percentages of positive findings. 
*Significantly smaller or larger compared with the other groups. 
HCC, hepatocellular carcinoma; HA, hepatocellular adenoma; NH, nodular hyperplasia 
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Table 2-5 
Summary of the characteristic CT findings in the dogs with other hepatic malignancies 
 
 
 
 
 
 
 
 
 
 HSA, hemangiosarcoma; CND, hepatic carcinoid tumor; LSA, lymphangiosarcoma 
 MMT, malignang mesenchymal tumor; MPNST, malignant peripheral nerve sheath tumor 
 Cyst, cyst like lesion; Capsule, capsule formation; LN, lymph node enlargement 
  
 
Maximum 
Diameter (mm) 
Cyst Capsule LN 
HSA (n=4) 50, 68, 68, 132 4 2 3 
CND (n=2) 50, 92 1 2 2 
Lymphoma (n=1) 52 1 1 1 
LSA (n=1) 142 1 1 0 
MMT (n=1) 114 1 1 1 
MPNST (n=1) 144 1 1 0 
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Figure 2-1 
 
Schema of the enhancement patterns in the arterial phase. (A) Central enhancement. Blood 
vessels are located at the center of the lesion. (B) Marginal enhancement. Blood vessels 
located along the margin. (C) Diffuse enhancenment. Blood vessels extending entirely 
within the lesion. 
  
A B
C
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Figure 2-2 
 
Transverse CT images of a patient with HCC. (A) Plain: Isoattenuating large mass lesion is 
present on the left middle lobe with calcification (arrowhead). (B) Arterial phase: Enhanced 
arteries are present in the center (arrow), and blood vessels are observed along the margins 
(arrowheads) of the tumor. (C) Portal phase: A thin, curved linear border represents the 
tumor capsule (arrowheads). This lesion showed hypoattenuation compared with the 
surrounding liver parenchyma. (D) Equilibrium phase: In the interior of the 
hypoattenuating mass, cyst-like lesions are observed (arrowheads). Enlarged lymph nodes 
are observed around the portal vein (arrows).  
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Figure 2-3 
 
Transverse CT images of a patient with HA. (A) Plain: Isoattenuating equivocal mass lesion 
is observed on the right middle lobe (arrow). (B) Arterial phase: Hyperattenuating mass 
lesion becomes distinct with a characteristic diffuse enhancement pattern (arrow). (C) 
Portal phase: The lesion retains its hyperattenuation compared with the surrounding liver 
parenchyma (arrow). (D) Equilibrium phase: The lesion becomes isoattenuating.  
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Figure 2-4 
 
Transverse image of a patient with NH. (A) Plain: Isoattenuating mass lesion is present on 
the left middle lobe (arrowheads). (B) Arterial phase: The lesion shows a diffuse 
enhancement pattern (arrow). (C, D) Portal and equilibrium phase: The lesion shows 
isoattenuation. 
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Figure 2-5 
 
Transverse image of a patient with hemangiosarcoma. (A) Plain: Hypo-attenuating mass 
lesions are present on the right middle lobe (arrowheads) and left middle lobe (arrows). (B, C, 
D) Arterial, portal and equilibrium phase: The lesions show hypo-attenuation compared to 
surrounding liver parenchyma during all phases. As arterial blood supply is observed in the 
arterial phase (arrowhead), it gradually becomes equivocal in the later phases. 
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Figure 2-6 
 
Transverse image of a patient with hepatic carcinoid tumor. (A) Plain: Since mass lesions 
are iso-attenuating, lesions are poorly demarcated from surrounding liver parenchyma. (B, 
C) Arterial and portal phase: Margin of the lesions is enhanced and lesions become extinct 
(arrowheads). (D) Equilibrium phase: Mass lesions become equivocal in this phase 
(arrowheads). 
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Figure 2-7 
 
Transverse image of a patient with hepatic carcinoid tumor. (A) Plain: Hypo-attenuated 
lesion is observed on the caudate lobe (arrowheads). (B) Arterial phase: Mass lesion show 
marginal enhancement (arrowheads) with central cystic lesion (*). Additional lesions are 
detected on the left lateral and right middle lobe in this phase (arrows). (C, D) Portal and 
equilibrium phase: Mass lesions with cystic lesions show hypo-attenuation compared to 
surrounding parenchyma (*). 
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Chapter 3 
Characterization of triple-phase 
computed tomography in dogs with 
pancreatic insulinoma 
 71 
Abstract 
 Little information is available regarding triple-phase computed 
tomography (CT) of canine pancreatic insulinoma. A few case reports have 
indicated that hyper-attenuation in the arterial phase was a common finding 
on multi-phasic CT in dogs with insulinoma. The aim of the study in this 
chapter was to clarify the characteristic findings of dogs with insulinoma on 
triple-phase CT. Nine dogs with insuolinoma that underwent triple-phase 
CT were included in the present study. Attenuation patterns in the arterial 
phase indicated hypo-attenuation in 4 cases and hyper-attenuation in 2 
cases. In the remaining 3 cases, 1 case showed hypo-attenuation and 1 case 
showed hyper-attenuation in the pancreatic phase, and 1 case presented 
hyper-attenuation in the later phase. Altogether, 5 cases showed hypo and 4 
cases showed hyper-attenuation in at least one phase. The enhancement 
pattern was homogenous in 7 cases and heterogeneous in 2 cases. Tumor 
margins were well-defined in 5 cases and ill-defined in 4 cases. Capsule 
formation was present in 5 cases and absent in 4 cases. For the further 
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evaluation, histopathological features were evaluated in comparison with CT 
characteristics in 3 cases. While correlation between attenuation patterns 
(hyper or hypo attenuation) in CT and connective tissue or vascular 
distribution was not observed, findings of tumor margin and capsule 
formation in CT corresponded to histopathological features. The present 
study indicated that hypo-attenuation was as common as hyper-attenuation 
in dogs with insulinoma in triple-phase CT at least one phase. Additionally, 
mass lesions were most conspicuous not only in the arterial phase but in the 
pancreatic and later phases in some cases. Therefore, it is important to 
perform triple-phase CT and notice about variable findings for the detection 
of canine pancreatic insulinoma.
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Introduction 
Insulinoma is the most common pancreatic endocrine tumor in dog 
(Goutal et al., 2012). Clinical signs are related to hypoglycemia resulting in 
seizure, weakness, collapse, posterior weakness, ataxia, muscle 
fasciculations, and lethargy. A tentative diagnosis relies on clinical signs, 
laboratory data such as the amended insulin glucose ratio (AIGR), and 
imaging diagnosis. While AIGR has high sensitivity in detection of 
pancreatic insulinoma in dogs, AIGR shows false positive result in 
hypoglycemic patient without insulin secreting tumor (Leifer et al., 1986). 
Therefore, visualization of a pancreatic mass lesion by imaging modality is 
quite essential and surgical removal of the tumor is needed for both 
definitive diagnosis and treatment. For an imaging diagnosis, 
ultrasonography (US) can be used to detect a mass lesion in the pancreas 
(Polton et al., 2007). The sensitivity of US in detecting insulinoma ranged 
from 28% to 75% (Lamb et al., 1995; Polton et al., 2007). However, the 
sensitivity of insulinoma detection is depending on the operator, and various 
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factors such as abdominal fat, gastrointestinal gas contents, and patient 
characteristics can interfere with a complete examination of the pancreas. 
Recently, contrast-enhanced ultrasonography (CEUS) has been applied for 
the detection of pancreatic insulinoma in dogs (Nakamura et al., 2014; 
Vanderperren et al, 2013). Although these reports describe the usefulness of 
CEUS with improved visualization of insulinoma lesions in dogs, this 
technique potentially has the same limitations described above. In contrast, 
computed tomography (CT) allows a full and thorough assessment of the 
entire pancreas. Therefore, CT is another important imaging modality for 
the detection of canine pancreatic insulinoma. It has been reported that 
conventional contrast-enhanced CT is a more sensitive imaging examination 
than non-contrast US or single-photon emission computed tomography 
(SPECT) (Robben et al., 2005). Since surgical removal is the first choice for 
the treatment of dogs with insulinoma, CT is superior to US for insulinoma 
localization and staging. 
In human medicine, the preoperative diagnostic utility of dual-phase 
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CT for pancreatic insulinoma has been well described (Gouya et al., 2003; 
Liu et al., 2009). It has been reported that this technique has promising 
sensitivity in the detection of insulinoma. These reports suggest that the 
arterial phase is important for detection; hyper-attenuation compared with 
the pancreatic parenchyma is a typical enhancement pattern in insulinoma. 
In addition, there is a report that mentioned triple-phase CT was more 
useful than dual-phase CT in the detection of insulinoma (Fidler et al., 2003). 
Their report suggested that the pancreatic phase was more important than 
the arterial phase in detecting insulinoma. 
In veterinary medicine, there have been 2 reports that described 
multi-phasic CT in dogs with insulinoma. The first report aimed to establish 
optimal enhancement conditions for pancreatic tumors in dogs on dynamic 
CT. In this report, 1 dog with insulinoma showed a hyper-enhanced lesion in 
the arterial phase (Iseri et al., 2007). In the second report, 3 dogs with 
insulinoma underwent dual-phase CT (Mai et al., 2008). While 2 cases 
showed hyper-attenuation in the arterial phase, the findings in 1 case were 
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equivocal to the surrounding pancreatic parenchyma. According to these 
reports, hyper-attenuation in the arterial phase may be a common finding on 
multi-phasic CT in dogs with insulinoma, as it is in humans. However, the 
number of cases was too small to draw conclusions regarding the features of 
multi-phasic CT in dogs with insulinoma. The purpose of the study in this 
chapter was to clarify the image features of dogs with insulinoma on 
triple-phase CT. 
Additionally, histopathological features in canine insulinoma have 
been reported to be variable in the following aspects: invasion into the 
surrounding pancreatic parenchyma, condensation of connective tissue, and 
the presence or absence of a fibrous capsule (Capen et al., 1969; Buishand et 
al., 2010; Madarame et al., 2009). As a thorough histopathological evaluation 
offers important information to differentiate imaging features (Capen et al., 
1969), comparison between the histopathological characteristics and CT 
findings was also carried out. 
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Materials and Methods 
 
Case selection 
A retrospective review of the medical records from the VMC-UTokyo 
was performed from April 2005 to June 2014. Inclusion criteria were as 
follows: (1) Dogs suspected to have pancreatic insulinoma by clinical 
symptoms (seizure, lethargy, and ataxia) and clinicopathological findings 
including increased amended insulin glucose ratio (AIGR；> 30); (2) Dogs 
that underwent triple-phase CT and the data were available for 
reevaluation; (3) Dogs with histopahological confirmation of pancreatic 
insulinoma. 
Clinical data including breed, age, sex, body weight, blood glucose 
and insulin levels, amended insulin glucose ratio (AIGR), and presence or 
absence of a mass lesion in the pancreas on US were collected from medical 
records. Histopathological findings related to metastates to regional lymph 
nodes or other organs were also obtained from medical records. 
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All patients had undergone an abdominal helical CT evaluation that 
included non-enhanced and contrast-enhanced triple-phase CT through the 
pancreas. Pancreatic triple-phase CT scanning was performed in the fixed 
method during the study period, which described previously with slight 
modification (Iseri et al., 2007). In most of the cases, CT images were 
acquired with a 4-row multi-detector helical CT unit (Asteion Super 4, 
Toshiba Medical Systems Corporation, Tochigi, Japan). In the latest 1 case, 
image was obtained with a 80-row multi-detector helical CT unit (Aquilion 
Prime, Toshiba Medical Systems Corporation). The patient was in dorsal 
recumbency and under general anesthesia. The tube rotation speed was 1 
second, slice thickness was 3 mm, and beam pitch was 0.875. The 
non-contrast plain CT scanning was initiated at the cranial aspect of the 
diaphragm and extended caudally to the level of the pelvic inlet. On arterial 
phase of triple-phase CT, the scan was initiated at the cranial aspect of the 
diaphragm and extended caudal end of pancreas. Scan area was extended 
caudally to the level of the pelvic inlet at pancreatic and equilibrium phase. 
 79 
Iohexol (300 mg I/ml, Omnipaque 300, Daiichi Sankyo Company. Ltd., Tokyo, 
Japan) was used as the contrast medium at a dose of 2 ml/kg and was 
injected with a power injector (A-300, Nemoto Kyorindo Co. Ltd., Tokyo, 
Japan) over 5 to 10 sec (depending on size of the patient) via the jugular vein. 
Scan delay was fixed and set as 15 seconds for the arterial phase, 30 seconds 
for the pancreatic phase and 90 seconds for the equilibrium phase after 
contrast medium injection started (Iseri et al., 2007). 
 
Imaging analysis 
Images were reviewed using OsiriX (Pixmeo, Geneva, Switzerland). 
Before image analysis, validity of each phase was assessed depending on 
following criteria (Fidler et al., 2003). The phase was considered as the 
arterial phase if there was enhancement of the arteries without 
enhancement of the cranial mesenteric vein. The phase was considered as 
the pancreatic phase if there was enhancement of the cranial mesenteric 
vein. The subsequent phase was classified as the later phase. If any of the 
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phases were not corresponded to the criteria, these cases were excluded from 
the present study. 
The features evaluated included location, size, margin demarcation 
(well-defined or ill-defined) and presence of a tumor capsule. A tumor 
capsule was defined as a thin curvilinear border that surrounded the tumor 
and had a distinct difference in attenuation. Presence or absence of 
lymphadenopathy and hepatic nodule were evaluated. 
Enhancement patterns were evaluated as homogenous or 
heterogeneous. The overall attenuation of the tumor was also noted, which 
was defined relative to the pancreatic parenchyma during the same phase of 
imaging (pre-contrast, arterial, pancreatic, or later phase). If the lesion had a 
different CT value in Hounsfield units (HU) (>20 HU compared with the 
surrounding pancreatic parenchyma), I deemed it to be different and 
considered these lesions to have hyper- or hypo-attenuation. The phase that 
presented the most different CT values between the lesion and pancreatic 
parenchyma was recorded as the most conspicuous phase. 
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Histopathological evaluation 
When the paraffin-embedded tissue samples were available, 
histopathological features were reevaluated by a veterinary pathologist 
unaware of the CT findings. The samples were sectioned at 4 µm and stained 
with hematoxylin and eosin (HE) and Masson’s trichrome. 
Immunohistochemistry was also performed by labeled streptavidin 
biotinylated antibody (LSAB) or by the EnVision Polymer method using goat 
serum against CD34 (1:80, Santa Cruz Biotechnology, CA, USA) and guinea 
pig polyclonal anti-insulin antibody (1:200, Dako, Glostrup, Denmark). 
The proliferation of connective tissue was investigated by Masson’s 
trichrome staining. Depending on the blue-stained area inside the lesion, the 
degree of connective tissue proliferation was assessed subjectively as mild, 
moderate, or severe. Distribution of the blood vessels was evaluated by 
counting CD34-positive branches. The numbers of branches were counted 
randomly in 5 high-power fields (×200), and then the mean and standard 
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deviation of the numbers of branches were calculated. Comparing these data, 
I classified each patient as relatively rich or poor in blood vessel distribution. 
I assessed the degree of capsule formation by evaluating the blue-stained 
area around the lesion of the Masson’s trichrome-stained specimens 
(well-encapsulated or non-encapsulated). It is because tumor cells of 
insulinoma were positively stained by anti-insulin immunohistochemistry, 
tumor invasiveness into the surrounding tissue was evaluated by 
anti-insulin immunohistochemistry (invasive or noninvasive). The 
histopathological features were evaluated in comparison with CT findings. 
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Results 
Nine dogs met the inclusion criteria. Clinical features of each 
patient are summarized in Table 3-1. The median blood glucose and insulin 
levels were 38 mg/dl (range, 32-50 mg/dl) and 24.2 µU/ml (1.8-312 µU/ml), 
respectively (Table 3-1). The median AIGR value was 200 (range, 90–3,900). 
Although all 9 cases underwent abdominal ultrasonography, mass lesions 
were identified in only 2 cases by US (22.2%). The mass lesions were 
detected in the right lobe in a case and in the left lobe in another case. On 
triple-phase CT, tumors were detected in the left lobe in 5 cases, in the right 
robe in 3 cases, and in the pancreatic body in 1 case. The median maximum 
diameter of the tumors was 12 mm (range; 9 – 20 mm). 
The overall attenuation on triple-phase CT is summarized in Table 
3-2. Four cases were hypo-attenuated (Figure 3-1) and other two cases were 
hyper-attenuated (Figure 3-2) compared with the pancreatic parenchyma at 
the arterial phase. One case showed hypo-attenuation and other 1 case 
showed hyper-attenuation at the pancreatic phase. The remaining one case 
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showed hyper-attenuation in the later phase. Altogether, five cases showed 
hypo-attenuation and four cases showed hyper-attenuation at least one 
phase. Of these 9 cases, 6 cases were most conspicuous in the arterial phase, 
2 cases were most conspicuous in the pancreatic phase (Figure 3-3) and 1 
case was most distinct in the later phase. Other CT findings are also 
summarized in Table 3-2. Enhancement patterns were homogenous in 7 
cases and heterogeneous in 2 cases. Margins were described as well-defined 
in 5 cases and ill-defined in 4 cases. Capsule formation was observed in 5 
cases. 
Lymphadenopathy was observed in 4 cases (hepatic lymph nodes in 
3 cases and splenic lymph nodes in 1 case). Of these 4 cases, a lymph node 
biopsy was performed in 2 cases (case Nos. 2, 6). While a case with contrast 
enhancement had the evidence of lymph node metastasis of insulinoma 
histopathologically, one case without enhancement diagnosed as lymph node 
hyperplasia. Although hyper-attenuated hepatic nodules were detected in 
one case in the arterial phase, liver biopsy was not performed and 
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histopathological evidence of metastasis was not confirmed in this case. 
 Parrafin-embedded blocks from 3 cases were available for further 
histopathological evaluation (case Nos 5, 8, and 9). Comparison between CT 
characteristics and histopathological evaluation is summarized in Table 3-3. 
The overall attenuation (hypo- or hyper-attenuation) and enhancement 
pattern (homogeneous or heterogeneous) were not histopathologically 
related to the severity of connective tissue proliferation or the density of 
blood vessels. However, patients with ill-defined tumor margins on CT 
corresponded to the histologic feature of invasiveness. Additionally, the 
presence or absence of a capsule on CT was also identical to the 
histopathological findings of the capsule in all 3 cases (Figure 3-4). 
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Discussion 
 In the study of this chapter, I described the image features of 
insulinoma on triple-phase CT in larger number of dogs than previous case 
reports. In previous reports of multi-phasic CT findings in canine insulinoma, 
an enhancement pattern of hyper-attenuation in the arterial phase was 
dominant (Iseri et al., 2007; Mai et al., 2008). However, in the present study, 
hypo-attenuation (4 cases) was more common than hyper-attenuation (2 
cases) in the arterial phase. 
It has been reported that hypo-attenuation was found as an atypical 
enhancement pattern in 13% of human insulinoma patients (Fidler et al., 
2003). The reason why hypo-attenuation is common in canine insulinoma 
compared to human was unknown. It has been reported that 
histopathological features in canine insulinoma were variable in the 
following aspects: invasion into the surrounding pancreatic parenchyma, 
condensation of connective tissue, and the presence or absence of a fibrous 
capsule (Buishand et al., 2012; Capen et al., 1969; Madarame et al., 2009). 
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Therefore, I evaluated histopathological findings in comparison with CT 
characteristics in this study. Pathological features including condensation of 
connective tissue and vascular distribution inside the lesion were not related 
to enhancement pattern in the triple-phase CT. However, invasion into the 
surrounding parenchyma and fibrous capsule formation corresponded to the 
image features of margin description and present or absent of tumor capsule. 
Since the finding of ill demarcated margin on CT might suggest tumor 
invasion to surrounding parenchyma histopathologically, it is important to 
ensure sufficient surgical margin if the clinicians are planning to resect 
insulinoma. Since the number of the cases was small in this study, further 
case accumulation is needed to improve the utility CT examination in 
veterinary medicine. 
In 6 out of 9 cases, mass lesions were most distinct in the arterial 
phase and corresponded to enhancement patterns in previous reports of dogs 
and humans with insulinoma (Gouya et al., 2003; Iseri et al., 2007; Liu et al., 
2009; Mai et al., 2008). However, 3 out of 9 cases presented a conspicuous 
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mass lesion in the pancreatic or the later phase. There is a report that 
suggests the importance of the pancreatic phase on triple-phase CT for the 
detection of insulinoma in humans (Fidler et al., 2003). Additionally, there is 
a report about CEUS in dogs with insulinoma that describes drastic changes 
in enhancement patterns for every moment (Nakamura et al., 2014). 
Therefore, multi-phasic CT is essential (triple-phase must be preferred to 
dual-phase) to obtain adequate image for the detection of canine insulinoma. 
Under the triple-phase CT in the present study; however, body weight and 
anesthetic condition which may affect the results of enhancement pattern of 
the pancreatic parenchyma or the tumor lesion were not factored in. 
Therefore, prospective study is needed to establish a more adequate protocol 
for multi-phasic CT on canine insulinoma such as test injection or 
bolus-tracking method. 
Additionally, in the present study, other CT findings of canine 
insulinoma demonstrated a wide variety. Seven cases presented homogenous 
enhancement patterns, while the other 2 cases showed heterogeneous 
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patterns. Capsule formation was found in 5 cases, but absent in 4 cases. 
These various enhancement patterns were corresponded with the variable 
findings in the CEUS literature reported previously (Nakamura et al., 2014). 
It is important to note that these variable findings might be observed when 
we evaluate canine insulinoma on CT examinations. 
 Lymphadenopathy was detected in 4 cases on CT. One out of 2 cases 
with a lymph node biopsy showed histopathological evidence of insulinoma 
metastasis. Enhancement pattern was consistent with primary tumors and 
metastatic lymph nodes at the same phase. Another case was found to be 
lymph node hyperplasia in the histopathological evaluation; contrast 
enhancement was not observed in all phases. An enhancement patterns 
comparable to that of the primary lesion in the pancreas might indicate 
lymph node metastasis. Although there was 1 case of suspected hepatic 
metastasis on CT, its biopsy was not performed. As the metastatic rate of 
canine insulinoma has been reported as 45 to 55% at the time of diagnosis 
(Goutal et al., 2012), it is important to carefully assess the liver and regional 
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lymph nodes and on CT when insulinoma is suspected. 
  While mass lesions in the pancreas were detected in only 2 cases by 
US, all of the mass lesions were detected by CT. This result corresponds to 
that of a previous study in which low sensitivity for the detection of canine 
insulinoma was reported for US (Robben et al., 2005). Additionally, a CT 
examination allows surgeons to consider surgical resection and plan the 
surgical procedure. Consequently, triple-phase CT is a superior imaging 
modality to non contrast-enhanced US as a diagnostic tool for canine 
insulinoma. 
 The present study had several limitations. First of all, by the nature 
of the retrospective study, triple-phase CT in the present study was 
performed in fixed scan delay despite different body weight and anesthetic 
condition of each case. For the large breed dogs, it takes more time for 
injection of contrast medium than the small breed dogs. That might result in 
reduced intensity of CT value in the pancreatic parenchyma or the tumor 
lesion in the large breed dogs. It may affect the results of enhancement 
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pattern in the present study. To reduce these potential technical problems, 
more applicable method for pancreatic CT imaging should be determined 
such as test injection or bolus-tracking method. Second, case number was 
small in the present study. Further case accumulation of the triple-phase CT 
is needed to make more certain evidence about image findings in canine 
pancreatic insulinoma. 
 In summary, I described the characteristics of canine insulinoma on 
triple-phase CT in this chapter. It is important to note that hypo-attenuation 
in at least one phase was as common as hyper- attenuation in dogs with 
insulinoma in triple-phase CT. Additionally, other variable features of 
canine insulinoma were identified including that homogenous and 
heterogeneous enhancement patterns were present, descriptions of tumor 
margins ranged from ill-defined to well-defined, and both the presence and 
absence of capsule formation were observed. Although the arterial phase is 
essential for the detection of canine insulinoma, the pancreatic and the later 
phase are needed to avoid missing detection of the lesion. It is important to 
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be familiar with the CT findings of canine insulinoma when a patient with 
suspected insulinoma is evaluated by CT imaging analysis. 
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Figure 3-1 
 
Transverse CT images of a patient with insulinoma (case 9). (A) Pre-contrast: the right lobe 
of the pancreas (arrowhead) was observed at the dorsal area of the duodenum (arrow). A 
mass lesion is not evident. (B) Arterial phase: a hypo-attenuating mass lesion with marginal 
ring enhancement is distinctly observed (arrowhead). The description of the margin was 
well-defined with a capsule. (C) Pancreatic phase: the hypo-attenuating mass lesion was 
still found in this phase, but gradually became equivocal. (D) Later phase: the mass lesion 
became more equivocal than in the early phases. 
 97 
Figure 3-2 
 
Transverse CT images of a patient with insulinoma (case 3). (A) Pre-contrast: the right lobe 
of the pancreas (arrowhead) was observed at the dorsal area of the duodenum (arrow). A 
mass lesion is not evident. (B) Arterial phase: a hyper-attenuating mass lesion is distinctly 
observed (arrowhead). The description of the margin was well-defined without a capsule. (C, 
D) Pancreatic and Later phases: the mass lesion became equivocal. It is difficult to 
distinguish the mass lesion from the pancreatic parenchyma. 
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Figure 3-3 
 
Transverse CT images of a patient with insulinoma (case 4). (A) Pre-contrast: the left lobe of 
the pancreas (*) was observed at the dorsal area of the stomach (stm). A raised lesion was 
seen, but is not evident (arrowhead). (B) Arterial phase: the mass lesion is not enhanced in 
this phase (arrowhead). (C) Pancreatic phase: the mass lesion is more distinctly enhanced 
than the pancreatic parenchyma (arrowhead). (D) Later phase: the lesion is still evident, but 
more equivocal than in the pancreatic phase. 
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Figure 3-4 
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Legend for Figure 3-4 
A comparison between the CT and histopathological findings. (A) Case 5. A 
hyper-attenuating and heterogeneous lesion is observed in the pancreatic left lobe in the 
arterial phase. The margin is ill-defined without capsule formation. (B) A Masson’s 
trichrome stain of the same lesion. Connective tissue proliferation was considered severe. 
Tumor invasion into the surrounding tissue is observed. Histopathological capsule 
formation is not present. (C) Case 7. A hypo-attenuating and heterogeneous lesion is 
observed in the pancreatic left lobe in the arterial phase. The tumor margin is well-defined 
with capsule formation (arrowheads). (D) A Masson’s trichrome stain of the same lesion. 
Connective tissue proliferation was considered mild. The tumor has a thin capsule, and 
invasion into the surrounding tissue was not observed. (E) Case 9. A hypo-attenuating and 
homogenous lesion is observed in the pancreatic right lobe in the arterial phase. The tumor 
margin is well-defined with capsule formation. (F) A Masson’s trichrome stain of the same 
lesion. Connective tissue proliferation was considered severe. The tumor has a capsule, and 
invasion into the surrounding tissue was not observed. 
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Conclusion  
 102 
Among several imaging modalities available in small animal 
medicine, CT has a potential to obtain comprehensive, objective and precise 
images in a relatively short time. Therefore, CT takes important part of 
diagnosis and classification of several hepatic and pancreatic diseases in 
human medicine. Although CT examination is indispensable for diagnosis 
and treatment planning of diseases addressed in this thesis, information 
regarding CT characteristics of these diseases is lacking. Therefore, I 
evaluated CT findings in dogs with portosystemic shunt, hepatic tumors and 
pancreatic insulioma to figure out the information that are useful to improve 
diagnostic accuracy of these diseases in this thesis. 
 In Chapter 1, canine extrahepatic congenital portosystemic shunts 
(EH-cPSS) were classified into several anatomic types, depending on their origin and 
termination of the shunt vessel. The aim of the study in this chapter was to determine 
the proportion and clinical features of each anatomical shunt type in a population of 
dogs presented to the VMC-UTokyo. Dogs diagnosed with EH-cPSS using CT 
portography were included (n = 172) and shunts were classified based on previous 
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reports. Clinical data were collected from case records and analyzed statistically. The 
most common anatomical type was the spleno-phrenic shunt (n = 64), followed by the 
spleno-azygos (n = 38), right gastric-caval (n = 29), spleno-caval (n = 21), right 
gastric-caval with caudal loop (n = 9), right gastric-phrenic (n = 6), colono-caval (n = 3), 
spleno-phrenic and azygos (n = 1), and porto-caval shunts (n = 1). Spleno-phrenic and 
spleno-azygos shunts were diagnosed significantly more frequently in older dogs than 
right gastric-caval and spleno-caval shunts (P < 0.05). The portal vein/aortic (PV/Ao) 
ratio was significantly larger in dogs with spleno-phrenic shunt than in dogs with the 
spleno-azygos, right gastric-caval or spleno-caval shunts (P < 0.05). The PV/Ao ratio 
was significantly larger in dogs with spleno-azygos shunts than in dogs with right 
gastric-caval shunts. Dogs with spleno-phrenic shunts had significantly lower serum 
alkaline phosphatase activities than those with right gastric-caval or spleno-caval shunts. 
Dogs with spleno-phrenic shunts had significantly lower fasting ammonia 
concentrations than those with spleno-caval shunts. Since several clinical features 
evaluated in this chapter were significantly different depending on shunt types, 
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thorough evaluation of shunt morphology by using CT portography is essential for the 
diagnosis of EH-cPSS in dogs. 
 In Chapter 2, the utility of triple-phase CT in differentiating hepatic 
mass forming lesions was described. Little information is available on the 
relationship between CT imaging findings and the pathologic diagnosis of canine 
hepatic tumors. The purpose of the study in this chapter was to clarify the characteristic 
features of CT findings in hepatic tumors in dogs. Data from 43 dogs with either a 
hepatocellular carcinoma (n = 14), hepatocellular adenoma (n = 14), nodular 
hyperplasia (n = 5), or other malignancies (n=10) were summarized from medical 
records. CT features for each hepatocellular tomor were characterized and analyzed 
statistically. Common findings in hepatocellular carcinoma included central (79%, P = 
0.036) and marginal enhancement (93%, P = 0.00043) in the arterial phase, cyst-like 
lesions (93%), capsule formation (93%), and hypoattenuation in the portal (86%, P = 
0.043), and in the equilibrium phases (93%, P = 0.013). Hepatic adenoma was 
characterized by a characteristic diffuse enhancement pattern during the arterial phase 
(57%, P = 0.0013), which was also found in nodular hyperplasia (60%), but never in 
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hepatocellular carcinoma. Nodular hyperplasia was less likely to have a capsule 
structure (20%, P = 0.0087). Mass size was significantly smaller in nodular hyperplasia 
than in hepatocellular carcinoma and hepatic adenoma (P = 0.0033 and 0.038, 
respectively). Hyperattenuation in the arterial and the portal phase i.e. contrast retention, 
was more frequent in hepatic adenoma than in the other groups (P = 0.032 and 0.032, 
respectively). Nodular hyperplasia was more frequently isoattenuating in the 
equilibrium phase (P = 0.043). In other malignancies group, all hemangiosarcoma (n=4) 
cases showed cyst-like lesions and hypo-attenuation in all phases. The patients with 
hepatic carcinoid tumor (n=2) showed contrast enhancement in the margin of the tumors 
in the arterial and portal phases. These findings will help to differentiate mass 
lesions in the canine liver on triple-phase CT examination. 
 In Chapter 3, characteristics on triple-phase CT in canine 
pancreatic insulinoma were described. No information regarding 
triple-phase CT of canine pancreatic insulinoma was available before this 
study. A few case reports indicated that hyper-attenuation in the arterial 
phase was a common finding on multi-phasic CT in dogs with insulinoma. 
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The aim of the study in this chapter was to clarify the characteristic findings 
of dogs with insulinoma on triple-phase CT. Nine dogs with insuolinoma that 
underwent triple-phase CT were included in the present study. Attenuation 
patterns in the arterial phase indicated hypo-attenuation in 4 cases and 
hyper-attenuation in 2 cases. In the remaining 3 cases, 1 case showed 
hypo-attenuation and 1 case showed hyper-attenuation in the pancreatic 
phase, and 1 case presented hyper-attenuation in the later phase. Altogether, 
5 cases showed hypo and 4 cases showed hyper-attenuation in at least one 
phase. The enhancement pattern was homogenous in 7 cases and 
heterogeneous in 2 cases. Tumor margins were well-defined in 5 cases and 
ill-defined in 4 cases. Capsule formation was present in 5 cases and absent in 
4 cases.  
 For the further evaluation, histopathological features including 
condensation of connective tissue, vascular distribution, invasiveness to 
surrounding tissue, and capsule formation were evaluated in comparison 
with CT characteristics in 3 cases. While correlation between attenuation 
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patterns (hyper or hypo attenuation) in CT and connective tissue or vascular 
distribution was not observed, findings of tumor margin (well or ill 
demarcated) and capsule formation (present or absent) in CT corresponded 
to their histopathological features.  
 The study in chapter indicated that hypo-attenuation was as common 
as hyper-attenuation in dogs with insulinoma in triple-phase CT at least one 
phase. Additionally, mass lesions were most conspicuous not only in the 
arterial phase but in the pancreatic and later phases in some cases. 
Therefore, it is important to perform triple-phase CT and notice about 
variable findings for the detection of canine pancreatic insulinoma. 
 In summary, I described in this thesis a series of clinically important 
CT findings for classification as well as detection and differentiation of 
hepatic and pancreatic diseases in dogs. The study in the Chapter 1 revealed 
that spleno-phrenic and spleno-azygos shunts are common types of canine 
EH-cPSS in Japan and they had specific clinical features such as being 
diagnosed at relatively older age and having sustained PV/Ao ratio. It is 
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important for the clinicians to notice about these facts. Since sustained 
PV/Ao ratio makes it difficult to detect EH-cPSS by using WSAVA 
standardized US procedure, novel US procedures that can detect these types 
of EH-cPSS are needed especially in Japan. By analyzing the CT 
portographic images in this chapter, it may be possible to develop new 
ultrasonographic diagnostic procedures for EH-cPSS consequently 
improving diagnostic accuracy of EH-cPSS in dogs. The study in the Chapter 
2 revealed CT imaging characteristics to differentiate hepatic tumors in dogs. 
Since similar research results have been accumulated in recent years, it may 
be possible to make a differential algorithm for canine hepatic tumors by 
combining the results in this chapter and reported results of multi-phasic CT. 
I am convincing that these results are helpful to ameliorate accuracy of 
differential diagnosis of hepatic tumors in triple-phase CT prior to surgical 
intervention. Finally, the study in the Chapter 3, I described novel CT 
findings in the pancreatic insulinoma such as hypo-attenuation of the lesions 
of pancreatic insulinoma in triple-phase CT. Although I could not clarify the 
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mechanism of this finding histopathologically, it is important for 
veterinarians to notice about this finding when evaluating CT findings in the 
dogs with insulinoma.   
 One of the biggest disadvantages of CT examination in small animal 
practice is need for anesthesia to keep the patients immobile. Recently, the 
development of multi-detector low CT brings high-speed imaging into reality. 
This technical innovation allows veterinarians to choose unanesthetized CT. 
Since the sharpness of the images obtained from unanesthetized CT is 
inferior to that from anesthetized CT, diagnostic utility is dependent on the 
quality of the images. As I described some specific findings of the hepatic and 
pancreatic diseases in dogs, these information will contribute for 
interpretation of images from unanesthetized CT in seriously ill dogs 
suffering from these diseases in near future. 
 In conclusion, a series of studies on CT examination for the hepatic and 
pancreatic disorders in dogs will contribute to accurate diagnosis and most 
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suitable therapeutic strategies in each patient, providing clinically useful 
progress in the field of veterinary diagnostic imaging.
 111 
Acknowledgements 
 112 
 I would like to express my deepest gratitude to Dr. Hajime Tsujimoto 
and Dr. Koichi Ohno for great support and advice during this study. I also 
would like to express my profound gratitude to Drs. Ryohei Nishimura, 
Reina Fujiwara, Kazuyuki Uchida, Naoaki Matsuki, Yasuhito Fujino, Ko 
Nakashima, Masashi Takahashi, Hideyuki Kanemoto and Masaya Tsuboi 
for support of my works. I would like to acknowledge the substantial help 
from Miss. Kie Yamamoto. 
 I wish to thank all the patients and their owners in my works and all 
the staffs in Veterinary Medical Center of the University of Tokyo and the 
Department of Veterinary Internal Medicine. 
Finally, I am most grateful to my family. My father, Mr. Kenji 
Fukushima, he is the most brave person I have ever seen and is the man who 
taught me how interesting it is to know something new. My mother, Mrs. 
Keiko Fukushima, she always devotedly supports us and becomes the 
ground of our families. My precious wife, Mrs. Ayano Fukushima, she 
provides me a great support and helps me at all times. My sweet daughter 
 113 
Rino Fukushima and my dear dog Gris, they always make me smile and 
deprive daily stress away from me. 
 114 
References 
 115 
Ballegeer, E.A., Adams, W.M., Dubielzig, R.R., Dubieizig, R.R., Paoloni, M.C., 
Klauer, J.M., Keuler, N.S., 2010. Computed tomography characteristics 
of canine tracheobronchial lymph node metastasis. Veterinary 
Radiology & Ultrasound 51, 397-403. 
Baron, R.L., Brancatelli, G., 2004. Computed tomographic imaging of 
hepatocellular carcinoma. Gastroenterology 127, 133-143. 
Bergman, J.R., 1985. Nodular hyperplasia in the liver of the dog: An 
association with changes in the Ito cell population. Veterinary 
Pathology 22, 427-438. 
Bertolini, G., 2010. Acquired portal collateral circulation in the dog and cat. 
Veterinary Radilogy & Ultrasound 51, 25-33. 
Brancatelli, G., Federle, M.P., Grazioli, L., Carr, B.I., 2002. Hepatocellular 
carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 
39 U.S. residents. Radiology 222, 89-94. 
Brancatelli, G., Federle, M.P., Katyal, S., Kapoor, V., 2002. Hemodynamic 
characterization of focal nodular hyperplasia using three-dimensional 
volume-rendered multidetector CT angiography. American Journal of 
Roentgenology 179, 81-85. 
Buishand, F.O., Kik, M., Kirpensteijn, J., 2010. Evaluation of 
clinico-pathological criteria and the Ki67 index as prognostic indicators 
in canine insulinoma. The Veterinary Journal 185, 62-67. 
Capen, C.C., Martin, S.L., 1969. Hyperinsulinism in dogs with neoplasia of 
the pancreatic islets. A clinical, pathologic, and ultrastructural study. 
Veterinary Pathology 6, 309-341. 
Center, S.A., 1996. Hepatic Vascular Diseases. In: Guilford, W.G., Center, 
S.A., Strombeck, R.D., Williams, D.A., Meyer, D.J., Small Animal 
Gastroenterology 3rd ed. W. B. Saunders, Philadelphia, pp. 802-846. 
Choi, J.Y., Lee, J.M., Sirlin, C.B., 2014. CT and MR imaging diagnosis and 
staging of hepatocellular carcinoma. Part I, Development, growth, and 
spread: Key pathologic and imaging aspects. Radiology 272, 635-654. 
Choi, J.Y., Lee, J.M., Sirlin, C.B., 2014. CT and MR imaging diagnosis and 
staging of hepatocellular carcinoma. Part II, Extracellular agents, 
hepatobiliary agents, and ancillary imaging features. Radiology 273, 
 116 
30-50. 
Choi, S.Y., Choi H.J., Lee K.J., Lee, Y.W., 2015. Establishment of optimal 
scan delay for multi-phase computed tomography using bolus-tracking 
technique in canine pancreas. The Journal of Veterinary Medical 
Science 77, 1049-1054. 
Cuccovillo, A., Lamb, C.R., 2002. Cellular features of sonographic target 
lesions of the liver and spleen in 21 dogs and a cat. Veterinary 
Radiology & Ultrasound 43, 275-278. 
Cullen, J.M., 2009. Summary of the World Small Animal Veterinary 
Association standardization committee guide to classification of liver 
disease in dogs and cats. Veterinary Clincs of North America Small 
Animal Practice 39, 395-418. 
D’anjou, M.A., Pennink, D., Cornejo, L., Pibarot, P., 2004. Ultrasonographic 
diagnosis of portosystemic shunting in dogs and cats. Veterinary 
Radiology & Ultrasound 45, 424-437. 
de la Santa, L.G., Perez Retortillo, J. A., Miguel, A. C., Klein, L. M., 2014. 
Radiology of pancreatic neoplasms: An update. World Journal of 
Gastrointestinal Oncology 6, 330-343. 
Fernandez, N.J., Kidney, B.A., 2007. Alkaline phosphatese: beyond the liver. 
Veterinary Clinical Pathology 36, 223-233. 
Fidler, J.L., Fletcher, J.G., Reading, C.C., Andrews, J.C. Thompson, G.B., 
Grant, C.S., Service, F.J., 2003. Preoperative detection of pancreatic 
insulinomas on multiphasic helical CT. American Journal of Radiology 
181, 775-780. 
Frank, P., Mahaffey, M., Egger, C., Cornell, K.K., 2003. Helical computed 
tomographic portography in ten normal dogs and ten dogs with a 
portosystemic shunt. Veterinary Radiology & Ultrasound 44, 392-400. 
Furlow, B.A., 2015. Computed tomography of pancreatitis and pancreatic 
cancer. Radiologic Technology 86, 645-668. 
Gaschen, L., 2009. Update on hepatobiliary imaging. Veterinary Clincs of 
North America Small Animal Practice 39, 439-467. 
Gerritzen-Bruning, M.J., van den Ingh, T.S.G.A.M., Rothuizen, J., 2006. 
Diagnostic value of fasting plasma ammonia and bile acid 
 117 
concentrations in the identification of portosysmic shunting in dogs. 
Journal of Veterinary Internal Medicine 20, 13-19. 
Goutal, C. M., Brugmann, B. L., Ryan, K. A., 2012. Insulinoma in dogs: a 
review. Journal of American Animal Hospital Association 48, 151-163. 
Gouya, H., Vignaux, O., Augui, J., Dousset, B., Palazzo, L., Louvel, A., 
Chaussade, S., Legmann, P., 2003. CT, endoscopic sonography, and a 
combined protocol for preoperative evaluation of pancreatic insulinomas. 
American Journal of Radiology 181, 987-992. 
Grazioli, L., Federle, M.P., Brancatelli, G., Ichikawa, T., Olivetti, L., Blachar, 
A., 2001. Hepatic adenomas: Imaging and pathologic findings. 
Radiographics 21, 877-892. 
Hattori, Y., Gabata, T., Zen, Y., Mochizuki, K., Kitagawa, H., Matsui, O., 
2010. Poorly enhanced areas of pancreatic adenocarcinomas on 
late-phase dynamic computed tomography comparison with 
pathological findings. Pancreas 39, 1263-1270. 
Hussain, S.M., Terkivatan, T., Zondervan, P.E., Lanjouw, E., de Rave, S., 
Ijzermans, J.N., de Man, R.A., 2004. Focal nodular hyperplasia: 
findings at State-of-the-Art MR imaging, US, CT, and pathologic 
analysis. Radiographics 24, 3-17. 
Iseri, T., Yamada, K., Chijiwa, K., Nishimura, R., Matsunaga, S., Fujiwara, 
R., Sasaki, N., 2007. Dynamic computed tomography of the pancreas in 
normal dogs and in a dog with pancreatic insulinoma. Veterinal 
Radiology & Ultrasound 48, 328-331. 
Jang, H.J., Yu, H., Kim, T.K. Imaging of focal liver lesions. 2009, Seminars 
in Roentgenology 44, 266-282. 
Kanemoto, H., Ohno, K., Nakashima, K., Takahashi, M., Fujino, Y., 
Nishimura, R., Tsujimoto, H., 2009. Characterization of canine focal 
liver lesions with contrast-enhanced ultrasound using a novel contrast 
agent-sonazoid. Veterinary Radiology & Ultrasound 50, 188-194. 
Kosovsky, J.E., Manfra-Marretta, S., Matthiesen, D.T., et al. 1989. Results of 
partial hepatectomy in 18 dogs with hepatocellular carcinoma. Journal 
of the American Animal Hospital Association 25, 203-206. 
Kutara, K., Seki, M., Ishikawa, C., et al., 2013. Triple-phase helical 
 118 
computed tomogramphy in dogs with hepatic masses. Veterinary 
Raidiology & Ultrasound 55, 7-15. 
Lamb, C.R., Simpson, K.W., Boswood, A., Matthewman, L.A., 1995. 
Ultrasonography of pancreatic neoplasia in the dog: a retrospective 
review of 16 cases. Veterinary Record 137, 65-68. 
Lee, Y.J., Lee, J.M., Lee, J.S., Park, B.H., Kim, Y.H., Han, J.K., Choi, B.I., 
2015. Hepatocellular carcinoma: diagnostic performance of 
multidetector CT and MR imaging – A systematic review. Radiology 275, 
97-109. 
Leifer, C.E., Peterson, M.E., Matus, R.E., 1986. Insulin-secreting tumor: 
diagnosis and medical and surgical management in 55 dogs. Journal of 
American Veterinary Medical Association 188, 60-64. 
Liptak, J.M., Dernell, W.S., Monnet, E., Powers, B.E., Bachand, A.M., 
Kenney, J.G., Withrow, S.J., 2004. Massive hepatocellular carcinoma 
in dogs: 48 cases (1992-2002). Journal of American Veterinary Medical 
Association 225, 1225-1230. 
Liu, Y., Song, Q., Jin, H.T., Lin, X.Z., Chen, K.M., 2009. The value of 
multidetector-row CT in the preoperative detection of pancreatic 
insulinomas. La Radiologia Medica 114, 1232-1238. 
Madarame, H., Kayanuma, H., Shida, T., Tsuchiya, R., 2009. Retrospective 
study of canine insulinomas: eight cases (2005-2008). Journal of 
Veterinary Medical Science 71, 905-911. 
Mai, W. and Caceres, A.V., 2008. Dual-phase computed tomographic 
angiography in three dogs with pancreatic insulinoma. Veterinary 
Radiology & Ultrasound 49, 141-148. 
Martin, R.A., 1993. Congenital portosystemic shunt in the dog and cat. 
Veterinary Clinics of North America: Small Animal Practice 23, 
609-623. 
Mehl, M.L., Kyles, A.E., Hardie, M., Kass, P.H., Adin, C.A., Flynn, A.K., De 
Cock, H.E., Gregory, C.R., 2005. Evaluation of ameroid ring constrictors 
for treatment for single extrahepatic portosystemic shunts in dogs: 168 
 119 
cases (1995-2001). Journal of American Veterinary Medical Association 
226, 2020-2030. 
Nakamura, K., Takagi, S., Sasaki, N., 2010. Contrast-enhanced 
ultrasonography for characterizeation of canine focal liver lesions. 
Veterinary Radiology & Ultrasound 51, 79-85. 
Nakamura, K., Lim, S.Y., Ochiai, K., Yamasaki, M., Ohta, H., Morishita, K., 
Takagi, S. and Takiguchi, M. 2014. Contrast-enhanced 
ultrasonographic findings in three dogs with pancreatic insulinoma. 
Veterinary Radiology & Ultrasound 56, 55-62. 
Nelson, N.C., Nelson, L.L., 2011. Anatomy of extrahepatic portosystemic 
shunts in dogs as determined by computed tomography angiography. 
Veterinary Radiology & Ultrasound 52, 498-506. 
Nyman, H.T., O'Brien, R.T., 2007. The sonographic evaluation of lymph 
nodes. Clincal Techniques in Small Animal Practice 22, 128-137. 
Patnaik, A.K., Hurvitz, A.I., Lieberman, P.H., 1980. Canine hepatic 
neoplasms: A clinicopathologic study. Veterinary Pathology 17, 553-564. 
Patnaik, A.K., Hurvitz, A.I., Lieberman, P.H., Johnson, G.F., 1981. Canine 
hepatocellular carcinoma. Veterinary Pathology 18, 427-438. 
Patnaik, A.K., Lieberman, P.H., Hurvitz, A.I., Johnson, G.F., 1981. Canine 
hepatic carcinoid. Veterinary Pathology 18, 445-453. 
Penninck, D.G., Zeyen, U., Taeymans, O.N., Webster, C.R., 2013. 
Ultrasonographic measurement of the pancreas and pancreatic duct in 
clinically normal dogs. American Journal of Veterinary Research 74, 
433-437. 
Polton, G. A., White, R. N., Brearley, M. J., Eastwood, J. M., 2007. Improved 
survival in a retrospective cohort of 28 dogs with insulinoma. Journal of 
Small Animal Practice 48, 151-156. 
Robben, J.H., Pollak, Y.W.E.A., Kirpensteijn, J., Boroffka, S.A.E.B., van den 
Ingh, T.S.G.A.M., Teske, E., Voorhout, G. 2005. Comparison of 
ultrasonography, computed tomography, and single-photon emission 
computed tomography for the detection and localization of canine 
insulinoma. Journal of Veterinary Internal Medidicne 19, 15-22. 
Strombeck, D.R., 1978. Clinicopathologic features of primary and metastatic 
 120 
neoplastic disease of the liver in dogs. Journal of American Veterinary 
Medical Association 173, 267-269. 
Strombeck, D.R, Guildford, W.G., 1996. Hepatic neoplasms. In: Strombeck 
DR, Guilford WG. Strombeck's Small Animal Gastroenterology. Third 
edition. Philadelphia. W.B. Saunders, pp 847-860. 
Szatmari, V., Rothuizen. J., 2006. Ultrasonographic identification and 
characterization of congenital portosystemic shunts and portal 
hypertensive disorders in dogs and cats. In: WSAVA Liver 
Standardization Group (Eds). WSAVA Standards for Clinical and 
Histological Diagnosis of Canine and Feline Liver Diseases. Elsivier, 
Philadelphia, pp. 15-39.  
Taniura, T., Marukawa, K., Yamada, K., Hikasa, Y, Ito, K., 2009. 
Differential diagnosis of hepatic tumor-like lesions in dog by using 
dynamic CT scanning. Hiroshima Journal of Medical Science 58, 17-24. 
van den Bossche, L., van Steenbeek, F.G., Favier, R.P., Kummeling, A., 
Leegwater, P.A.J., Rothuizen, J., 2012. Dsitribution fo extrahepatic 
congenital portosystemic shunt morphology in predisposed dog breeds. 
BMC Veterinary Research 8, 112. 
Vanderperren, K., Haers, H., van der Vekens, E., Stock, E., Paepe, D., 
Daminet, S. Saunders, J. H. 2013. Description of the use of contrast 
enhanced ultrasonography in four dogs with pancreatic tumors. Journal 
of Small Animal Practice 55, 164-169. 
Winter, M. D., Kinney, L. M., Kleine, L.J., 2005. Three-dimensional helical 
computed tomographic angiography of the liver in five dogs. Veterinary 
Radiology & Ultrasound 46, 494-499. 
Zwingenberger, A.L., Schwarz, T., Saunders, M., 2005. Helical computed 
tomographic angiography of canine portosystemic shunts. Veterinary 
Radiology & Ultrasound 46, 27-32. 
